Clinical trial
Possible Effects of Supplementation With Cis-9, Trans-11 Conjugated Linoleic Acid on Markers of Atherosclerosis
NCT00706745 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Possible Effects of Supplementation With Cis-9, Trans-11 Conjugated Linoleic Acid on Markers of Atherosclerosis
- Lead sponsor
- UMC Utrecht
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 30, 2007
- Completion date
- December 31, 2008
- Enrollment
- 401 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.